Sign In
Buy CC
$22.61
-0.640 (-2.75%)
At Close: Jun 03, 2026
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours”
NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible v
CC Investors Encouraged to Join The Chemours Company Fraud Investigation With The Schall Law Firm
03:15pm, Friday, 09'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Com
The Chemours Company Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - CC
10:15am, Friday, 09'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible v
NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
09:30am, Friday, 09'th Aug 2024
NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised
The Chemours Company Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CC
05:40pm, Thursday, 08'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible v
NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible v
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
12:15pm, Wednesday, 07'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / 2024 (ACCESSWIRE) Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such invest
Chemours (CC) Earnings Miss, Revenues Beat Estimates in Q2
11:22am, Monday, 05'th Aug 2024
Chemours' (CC) earnings miss estimates in the second quarter due to lower selling prices.
The Chemours Company (CC) Q2 2024 Earnings Call Transcript
01:58pm, Friday, 02'nd Aug 2024
The Chemours Company (NYSE:CC ) Q2 2024 Earnings Conference Call August 2, 2024 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - SVP, CFO &
Chemours (CC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
08:35pm, Thursday, 01'st Aug 2024
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Chemours (CC) Misses Q2 Earnings Estimates
07:15pm, Thursday, 01'st Aug 2024
Chemours (CC) came out with quarterly earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $1.10 per share a year ago.
The Chemours Company Reports Second Quarter 2024 Results
04:15pm, Thursday, 01'st Aug 2024
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Second Quarter 2024 Results.
